Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FWQW8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
Stelara, a biologic medication commonly used for immunological conditions, will be delivered to the place of performance in Park Ridge, Illinois. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure multiple delivery orders from the DLA covering an extensive portfolio of prescription drugs, biologics, and medical consumables. The company's consistent performance under the SPE2DB contract demonstrates its capacity to reliably distribute specialized pharmaceutical products to Department of Defense healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DB25FWQW8?
SPE2DB25FWQW8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FWQW8 worth?
The government has obligated $16,250 on SPE2DB25FWQW8.
Is contract SPE2DB25FWQW8 an order under another contract?
Yes. SPE2DB25FWQW8 is a delivery order under SPE2DB24D9218, an indefinite delivery contract.
Was contract SPE2DB25FWQW8 competed?
The extent of competition for SPE2DB25FWQW8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award